Evidence Hub

Serum cytokines in primary new daily persistent headache and chronic migraine: a case control study

Sanjay Cheema, E. Garr, Dwij Mehta, Miles D. Chapman, Melanie S. Hart, M. Lunn, V. Iodice, M. Matharu

Frontiers in Neurology, 2025

40 participants · 2 citations

Abstract

Background New daily persistent headache (NDPH) is a poorly understood headache disorder which often begins after a viral infection and has been hypothesised to have an immune basis. Several studies have found differences in peripheral serum cytokine levels between healthy controls and patients with other primary headache disorders such as migraine. We sought to measure peripheral levels of cytokines and chemokines in NDPH, chronic migraine (CM), and healthy controls, to identify any changes which could be biomarkers of inflammation in NDPH. Methods We performed an observational prospective case control study measuring serum cytokine levels in three age and sex matched groups of 40 patients each: patients with NDPH, patients with CM with similar headache frequency and severity, and healthy controls. We accounted for confounders such as infective or autoimmune illness, vaccinations, comorbidities, and medications. We used a 30-PLEX human cytokine immunoassay to measure the concentration of 30 cytokines and chemokines. The primary outcome measures were differences in median concentrations of TNF-α, IL-6, and IL-8 between the three groups, as these are the three cytokines found to differ between chronic migraine and healthy controls in a recent meta-analysis. Results Age and sex distribution was balanced between the groups. The NDPH and daily CM groups were balanced on headache frequency, severity, and duration. The concentration of IL-6 was higher in both NDPH (median 0.603…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free